JNGLX
Price
$66.74
Change
-$0.42 (-0.63%)
Updated
Jun 13 closing price
Net Assets
4.35B
PHLQX
Price
$42.23
Change
-$0.32 (-0.75%)
Updated
Jun 13 closing price
Net Assets
1.4B
Interact to see
Advertisement

JNGLX vs PHLQX

Header iconJNGLX vs PHLQX Comparison
Open Charts JNGLX vs PHLQXBanner chart's image
Janus Henderson Global Life Sciences D
Price$66.74
Change-$0.42 (-0.63%)
VolumeN/A
Net Assets4.35B
PGIM Jennison Health Sciences R6
Price$42.23
Change-$0.32 (-0.75%)
VolumeN/A
Net Assets1.4B
JNGLX vs PHLQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JNGLX vs. PHLQX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Buy and PHLQX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.35B vs. PHLQX (1.4B). PHLQX pays higher dividends than JNGLX: PHLQX (0.96) vs JNGLX (0.36). JNGLX was incepted earlier than PHLQX: JNGLX (26 years) vs PHLQX (9 years). JNGLX (0.80) and PHLQX (0.77) have similar cost to investors . PHLQX is a more actively managed with annual turnover of: 79.00 vs. JNGLX (35.00). PHLQX has a lower initial minimum investment than JNGLX: PHLQX (0) vs JNGLX (2500). JNGLX annual gain was more profitable for investors over the last year : -11.98 vs. PHLQX (-16.38). JNGLX return over 5 years is better than : 13.58 vs. PHLQX (-17.77).
JNGLXPHLQXJNGLX / PHLQX
Total Expense Ratio0.800.77104%
Annual Report Gross Expense Ratio0.800.77104%
Fund Existence26 years9 years-
Gain YTD-1.694-3.93543%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.35B1.4B312%
Annual Yield % from dividends0.360.9638%
Returns for 1 year-11.98-16.3873%
Returns for 3 years20.7116.98122%
Returns for 5 years13.58-17.77-76%
Returns for 10 years12.35N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRMD18.650.50
+2.75%
TORM plc
INSM98.731.85
+1.91%
Insmed
CATX3.17-0.05
-1.55%
Perspective Therapeutics
DLTH1.83-0.11
-5.67%
Duluth Holdings
ABP0.22-0.02
-7.05%
Abpro Holdings Inc